Vaxart Inc NB11-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:08 AM CET
6.45quote price arrow up+0.10 (+1.57%)
Volume
600
52 week range
0.98 - 21.00

...

Loading . . .

KEY STATS

  • Open6.45
  • Day High6.45
  • Day Low6.45
  • Prev Close6.35
  • 52 Week High21.00
  • 52 Week High Date02/03/21
  • 52 Week Low0.98
  • 52 Week Low Date02/24/20
  • Market Cap782.7M
  • Shares Out109.47M
  • 10 Day Average Volume12,473.2
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change222.5

RATIOS/PROFITABILITY

  • EPS (TTM)-0.30
  • P/E (TTM)-21.50
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/09/2012
  • Div Amount6.648
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Vaxart, Inc., formerly Aviragen Therapeutics, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial;...
Wouter Latour M.D.
Chairman
Andrei Floroiu
Chief Executive Officer
Margaret Echerd
Chief Accounting Officer
Address
385 Oyster Point Boulevard, Suite 9A
South San Francisco, CA
94080
United States